Literature DB >> 7600618

Stability of a 1 beta-methylcarbapenem antibiotic, meropenem (SM-7338) in aqueous solution.

Y Takeuchi1, M Sunagawa, Y Isobe, Y Hamazume, T Noguchi.   

Abstract

The stability and the degradation products of 1 beta-methylcarbapenem, meropenem in aqueous solution were investigated. In pH 4-8 dilute solution, pseudo-first-order degradation was observed, and good stability of meropenem in aqueous solution was demonstrated by the effect of 1 beta-methyl group against hydrolysis of beta-lactam ring. As degradation products, the beta-lactam hydrolyzed product and the dimer product resulting from intermolecular aminolysis of beta-lactam ring by the amine of the second molecule were described.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7600618     DOI: 10.1248/cpb.43.689

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  10 in total

1.  Meropenem-clavulanic acid shows activity against Mycobacterium tuberculosis in vivo.

Authors:  Kathleen England; Helena I M Boshoff; Kriti Arora; Danielle Weiner; Emmanuel Dayao; Daniel Schimel; Laura E Via; Clifton E Barry
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

2.  In Vitro Stabilifighty Evaluation of Different Pharmaceutical Products Containing Meropenem.

Authors:  Cristina Tomasello; Anna Leggieri; Roberta Cavalli; Giovanni Di Perri; Antonio D'Avolio
Journal:  Hosp Pharm       Date:  2015-04-08

3.  Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.

Authors:  M E Falagas; L McDermott; D R Snydman
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

4.  Preparation, gram-negative antibacterial activity, and hydrolytic stability of novel siderophore-conjugated monocarbam diols.

Authors:  Mark E Flanagan; Steven J Brickner; Manjinder Lall; Jeffrey Casavant; Laura Deschenes; Steven M Finegan; David M George; Karl Granskog; Joel R Hardink; Michael D Huband; Thuy Hoang; Lucinda Lamb; Andrea Marra; Mark Mitton-Fry; John P Mueller; Lisa M Mullins; Mark C Noe; John P O'Donnell; David Pattavina; Joseph B Penzien; Brandon P Schuff; Jianmin Sun; David A Whipple; Jennifer Young; Thomas D Gootz
Journal:  ACS Med Chem Lett       Date:  2011-03-02       Impact factor: 4.345

5.  Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).

Authors:  Eric Viaene; Hugues Chanteux; Hélène Servais; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

6.  Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus.

Authors:  Amit Kaushik; Nayani Makkar; Pooja Pandey; Nicole Parrish; Urvashi Singh; Gyanu Lamichhane
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

7.  Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems.

Authors:  T Köhler; M Michea-Hamzehpour; S F Epp; J C Pechere
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

8.  Synthesis, pH-dependent, and plasma stability of meropenem prodrugs for potential use against drug-resistant tuberculosis.

Authors:  Aaron M Teitelbaum; Anja Meissner; Ryan A Harding; Christopher A Wong; Courtney C Aldrich; Rory P Remmel
Journal:  Bioorg Med Chem       Date:  2013-05-24       Impact factor: 3.641

9.  Direct Colorimetry of Imipenem Decomposition as a Novel Cost-Effective Method for Detecting Carbapenemase-Producing Enterobacteria.

Authors:  Stathis D Kotsakis; Anastasia Lambropoulou; Georgios Miliotis; Eva Tzelepi; Vivi Miriagou; Leonidas S Tzouvelekis
Journal:  Microbiol Spectr       Date:  2022-07-19

10.  Investigation of meropenem stability after reconstitution: the influence of buffering and challenges to meet the NHS Yellow Cover Document compliance for continuous infusions in an outpatient setting.

Authors:  Conor Jamieson; Michael Charles Allwood; Donata Stonkute; Andrew Wallace; Alan-Shaun Wilkinson; Tim Hills
Journal:  Eur J Hosp Pharm       Date:  2019-01-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.